Zimmer Biomet Holdings, Inc. has set its fourth quarter 2025 earnings release for Tuesday, February 10, 2026, with a detailed news release to be distributed at 6:30 a.m. ET and a live webcast conference call at 8:30 a.m. ET. Investors can access the audio webcast via the company’s Investor Relations website and replay the session thereafter. U.S. and Canadian participants may dial (800) 330-6710 using conference ID 7090861, while international callers should use +1 (213) 279-1505 and the same ID. This announcement gives institutional and retail shareholders ample notice to analyze full-quarter financials, management commentary and guidance that will influence next quarter’s outlook.

Ivan Tornos, President, CEO and Chairman of Zimmer Biomet, opened his presentation by underscoring the company’s 90-plus years of leadership and its footprint across 25 countries with sales in more than 100 markets. He committed to a concise one-minute overview of the past five years of operational performance before delving into 15 minutes of slides detailing revenue diversification in digital and robotic technologies, enhanced data analytics and AI integration within the product portfolio. Tornos emphasized how integrated surgical solutions and next-generation joint replacement systems have driven mid-single-digit organic growth, positioning the company for sustained margin expansion as it leverages its global distribution network and progressive culture of innovation.